Reversing the effects of fragile X syndrome.
Ogren
Marilee P
MP
Department of Biology, Boston College, Chestnut Hill, MA 02467-3800, USA. ogren@MIT.edu
Lombroso
Paul J
PJ
D000818:Animals; D003712:Dendrites / Q000378:metabolism; D051860:Fragile X Messenger Ribonucleoprotein 1 / Q000235:genetics; D005600:Fragile X Syndrome / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D006801:Humans; D051379:Mice; D012333:RNA, Messenger / Q000235:genetics; D064529:Receptor, Metabotropic Glutamate 5; D017470:Receptors, Glutamate / Q000235:genetics / Q000378:metabolism; D018094:Receptors, Metabotropic Glutamate / Q000037:antagonists & inhibitors* / Q000235:genetics; D013116:Spinal Cord / Q000473:pathology
D051860:Fragile X Messenger Ribonucleoprotein 1; D012333:RNA, Messenger; D064529:Receptor, Metabotropic Glutamate 5; D017470:Receptors, Glutamate; D018094:Receptors, Metabotropic Glutamate; C497683:FMR1 protein, human